The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression

British Journal of Nutrition

Volumn 99, Issue 2, 2008, Pages 303-310

  Wang, Yun ^a   Man Gho, Wai ^a   Chan, Franky I ^a   Chen, Shiuan ^b   Leung, Lai K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aromatase; Biochanin A; Breast cancer cells

Indexed keywords

AROMATASE; BIOCHANIN A; DAIDZEIN; ESTROGEN RECEPTOR; GENISTEIN; ISOFLAVONE; LUCIFERASE; MESSENGER RNA;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE REPRESSION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RED CLOVER; TRANSCRIPTION REGULATION;

AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENISTEIN; HUMANS; PHYTOESTROGENS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRIFOLIUM; TUMOR CELLS, CULTURED;

TRIFOLIUM PRATENSE;

EID: 38049109784     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507811974     Document Type: Article

References (47)

1. International Agency for Research on Cancer (1999) Hormonal Contraception and Post-menopausal Hormonal Therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 72, Lyon, France: IARC Press.
2. Pike MC & Spicer DV (1993) The chemoprevention of breast cancer by reducing sex steroid exposure: Perspectives from epidemiology. J Cell Biochem Suppl 17G, 26-36.
3. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P & Pasternack BS (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87, 190-197.
4. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT & Hamalainen E (1994) Estrogen metabolism and excretion in oriental and Caucasian women. J Natl Cancer Inst 86, 1076-1082.
5. Colditz GA (1999) Hormones and breast cancer: Evidence and implications for consideration of risks and benefits of hormone replacement therapy. J Womens Health 8, 347-357.
6. Liehr JG (2000) Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21, 40-54.
7. Liehr JG, Fang WF, Sirbasku DA & Ari-Ulubelen A (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 24 353-356.
8. Li JJ & Li SA (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 46, 1858-1863.
9. Zhu BT & Cooney AH (1998) Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis 19, 1-27.
10. Yared E, McMillan TJ & Martin FL (2002) Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the Comet assay. Mutagenesis 17, 345-352.
11. Zhang F, Swanson SM, van Breemen RB, Liu X, Yang Y, Gu C & Bolton JL (2001) Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: Formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases. Chem Res Toxicol 14 1654-1659.
12. Yoshidome K, Shibata MA, Couldrey C, Korach KS & Green JE (2000) Estrogen promotes mammary tumour development in C3(1)/SV40 large T-antigen transgenic mice: Paradoxical loss of estrogen receptor (expression during tumour progression. Cancer Res 60, 6901-6910.
13. Tsai MJ & O'Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann Rev Biochem 63, 451-486.
14. Dickson RB, Kasid A, Huff KK, Bates SE, Knabbe C, Bronzert D, Gelmann EP & Lippman ME (1987) Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 β-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci USA 84, 837-841.
15. Leung LK & Wang TT (1999) Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7. Br J Cancer 81, 387-392.
16. Watson CS, Norfleet AM, Pappas TC & Gametchu B (1999) Rapid actions of estrogens in GH3/B6 pituitary tumour cells via a plasma membrane version of estrogen receptor-α. Steroids 64, 5-13.
17. Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR & Simpson ER (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 264, 19385-19391.
18. Toda K, Terashima M, Kawamoto T, et al. (1990) Structural and functional characterization of human aromatase P-450 gene. Eur J Biochem 193, 559-565.
19. Harada, N, Yoshimura N & Honda S (2003) Unique regulation of expression of human aromatase in the placenta. J Steroid Biochem Mol Biol 86, 327-334.
20. Lee KM, Abel J, Ko Y, et al. (2003) Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. Br J Cancer 88, 675-678.
21. Cuzick J (2003) Aromatase inhibitors in prevention - data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study). Recent Results Cancer Res 163, 96-103, 264-266.
22. Jeong H-J, Shin YG, Kim L-H & Pezzuto JM (1999) Inhibition of aromatase activity by flavonoids. Arch Pharm Res 22, 309-312.
23. Kao YC, Zhou C, Sherman M, Laughton CA & Chen S (1998) Molecular basis of the inhibition of human aromatase (estrogen synthethase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect 106, 85-92.
24. Van Meeuwen JA, Korthagen N, de Jong PC, Piersma AH & van den Berg M (2007) (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol Appl Pharmacol 221, 372-383.
25. Brueggemeier RW, Hackett JC & Diaz-Cruz ES (2005) Aromatase inhibitors in the treatment of breast cancer. Endocr Reviews 26, 331-345.
26. Chen S, Zhou D, Okubo T, Kao Y-C & Yang C (1999) Breast tumor aromatase: functional role and transcriptional regulation. Endocr Relat Cancer 6, 149-156.
27. Zhou DJ, Pompon D & Chen SA (1990) Stable expression of human aromatase complementary DNA in mammalian cells: A useful system for aromatase inhibitor screening. Cancer Res 50, 6949-6954.
28. Grube BJ, Eng ET, Kao YC, Kwon A & Chen S (2001) White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr 131, 3288-3293.
29. Wang Y, Lee KW, Chan FL, Chen S & Leung LK (2006) The red wine polyphenol resveratrol displays bi-level inhibition on aromatase in breast cancer cells. Toxicol Sci 92, 71-77.
30. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
31. Wang Y, Chan FL, Chen S & Leung LK (2005) The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase. Life Sci 77, 39-51.
32. Peterson TG, Coward L, Kirk M, Falany CN & Barnes S (1996) The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis 17, 1861-1869.
33. Heinonen S-M, Wahala K & Adlercreutz H (2004) Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects. J Agric Food Chem 52, 6802-6809.
34. Rice S, Mason HD & Whitehead SA (2006) Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulose-luteal cells. J Steroid Biochem Mol Biol 101, 216-225.
35. Eng ET, William D, Mandava U, Kirma N, Tekmal RR & Chen S (2001) Suppression of aromatase (estrogen synthetase) by red wine phytochemicals. Breast Cancer Res Treat 67, 133-146.
36. Eng ET, Ye J, Williams D, Phung S, Moore RE, Young MK, Gruntmanis U, Braustein G & Chen S (2003) Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res 63 8516-8522.
37. Le Bail JC, Pouget C, Fagnere C, Basly JP, Chulia AJ & Habrioux G (2001) Chalcones are potent inhibitors of aromatase and 17(-hydroxysteroid dehydrogenase activities. Life Sci 68, 751-761.
38. Kao YC, Zhou C, Sherman M, Laughton CA & Chen S (1998) Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect 106, 85-92.
39. Simpson ER, Zhao Y, Agarwal VR, et al. (1997) Aromatase expression in health and disease. Recent Prog Horm Res 52, 185-213-213-214.
40. Diaz-Cruz ES, Shapiro CL & Brueggemeier RW (2005) Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J Clin Endocrinol Metab 90, 2563-2570.
41. Kinoshita Y & Chen S (2003) Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor α. Cancer Res 63, 3546-3555.
42. Vanden Berghe W, Dijsselbloem N, Vermeulen L, Ndlovu N, Boone E & Haegeman G (2006) Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-κB gene expression by soy isoflavones does not require estrogenic activity. Cancer Res 66, 4852-4862.
43. Gotoh T, Yamada K, Yin H, Ito A, Kataoka T & Dohi K (1998) Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res 89, 137-142.
44. Mizunuma H, Kanazawa K, Ogura S, Otsuka S & Nagai H (2002) Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer. Oncology 62 78-84.
45. Chan HY, Wang H & Leung LK (2003) The red clover (Trifolium pratense isoflavone biochanin A modulates the biotransformation pathways of 7,12-dimethylbenz-[a]anthracene. Br J Nutr 90, 87-92.
46. Sun XY, Plouzek CA, Henry JP, Wang TT & Phang JM (1998) Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. Cancer Res 58, 2379-2384.
47. Moon YJ, Sagawa K, Frederick K, Zhang S & Morris ME (2006) Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J 8, E433-E442.